Vancomycin-resistance gene cluster, vanC, in the gut microbiome of acute leukemia patients undergoing intensive chemotherapy


Autoři: Armin Rashidi aff001;  Zhigang Zhu aff002;  Thomas Kaiser aff002;  Dawn A. Manias aff004;  Shernan G. Holtan aff001;  Tauseef Ur Rehman aff005;  Daniel J. Weisdorf aff001;  Alexander Khoruts aff003;  Gary M. Dunny aff004;  Christopher Staley aff002
Působiště autorů: Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, United States of America aff001;  Department of Surgery, University of Minnesota, Minneapolis, MN, United States of America aff002;  BioTechnology Institute, University of Minnesota, St. Paul, MN, United States of America aff003;  Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN, United States of America aff004;  Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Minnesota, Minneapolis, MN, United States of America aff005
Vyšlo v časopise: PLoS ONE 14(10)
Kategorie: Research Article
doi: 10.1371/journal.pone.0223890

Souhrn

Two recent reports suggested that the less common, less virulent enterococcal species, Enterococcus gallinarum and E. casseliflavus, with low-level vancomycin resistance due to chromosomally encoded vanC1 and vanC2/3, may influence host immunity. We reported that peri-transplant gut colonization with E. gallinarum and E. casseliflavus is associated with lower mortality after allogeneic hematopoietic cell transplantation (HCT). Because most acute leukemia patients undergoing HCT have received intensive chemotherapy (usually requiring prolonged hospitalization) for their underlying disease before HCT, we hypothesized that some may have acquired vanC-positive enterococci during chemotherapy. Therefore, we evaluated the presence of the vanC gene cluster using vanC1 and vanC2/3 qPCR in thrice-weekly collected stool samples from 20 acute leukemia patients undergoing intensive chemotherapy. We found that an unexpectedly large proportion of patients have detectable vanC1 and vanC2/3 (15% and 35%, respectively) in at least one stool sample. Comparing qPCR results with 16S rRNA gene sequencing results suggested that E. gallinarum may reach high abundances, potentially persisting into HCT and influencing transplant outcomes.

Klíčová slova:

Acute myeloid leukemia – Antibiotics – Cancer chemotherapy – Cancer treatment – Enterococcus – Chemotherapy – Leukemias – Enterococcus infections


Zdroje

1. Bilinski J, Robak K, Peric Z, Marchel H, Karakulska-Prystupiuk E, Halaburda K, et al. Impact of Gut Colonization by Antibiotic-Resistant Bacteria on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective, Single-Center Study. Biol Blood Marrow Transplant. 2016;22: 1087–1093. doi: 10.1016/j.bbmt.2016.02.009 26900084

2. Scheich S, Lindner S, Koenig R, Reinheimer C, Wichelhaus TA, Hogardt M, et al. Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia. Cancer. 2018;124: 286–296. doi: 10.1002/cncr.31045 28960264

3. Scheich S, Reinheimer C, Brandt C, Wichelhaus TA, Hogardt M, Kempf VAJ, et al. Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study. Biol Blood Marrow Transplant. 2017;23: 1455–1462. doi: 10.1016/j.bbmt.2017.05.016 28528711

4. Taur Y, Xavier JB, Lipuma L, Ubeda C, Goldberg J, Gobourne A, et al. Intestinal Domination and the Risk of Bacteremia in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Clin Infect Dis. 2012;55: 905–914. doi: 10.1093/cid/cis580 22718773

5. Ubeda C, Taur Y, Jenq RR, Equinda MJ, Son T, Samstein M, et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J Clin Invest. 2010;120: 4332–4341. doi: 10.1172/JCI43918 21099116

6. Faron ML, Ledeboer NA, Buchan BW. Resistance Mechanisms, Epidemiology, and Approaches to Screening for Vancomycin-Resistant Enterococcus in the Health Care Setting. Kraft CS, editor. J Clin Microbiol. 2016;54: 2436–2447. doi: 10.1128/JCM.00211-16 27147728

7. Brodrick HJ, Raven KE, Harrison EM, Blane B, Reuter S, Török ME, et al. Whole-genome sequencing reveals transmission of vancomycin-resistant Enterococcus faecium in a healthcare network. Genome Med. 2016;8: 4. doi: 10.1186/s13073-015-0259-7 26759031

8. O’Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;8: 217–30. doi: 10.2147/IDR.S54125 26244026

9. Burger T, Fry D, Fusco R, Luschini M, Mayo JB, Ng V, et al. Multihospital surveillance of nosocomial methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and Clostridium difficile: Analysis of a 4-year data-sharing project, 1999–2002. Am J Infect Control. 2006;34: 458–464. doi: 10.1016/j.ajic.2005.08.010 16945694

10. Rashidi A, Ebadi M, Shields-Cutler RR, DeFor TE, Al-Ghalith GA, Ferrieri P, et al. Pretransplant Gut Colonization with Intrinsically Vancomycin-Resistant Enterococci (E. gallinarum and E. casseliflavus) and Outcomes of Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2018; doi: 10.1016/j.bbmt.2018.01.025 29407252

11. Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science (80-). 2018;359: 1156–1161. doi: 10.1126/science.aar7201 29590047

12. Rashidi A, Kaiser T, Shields-Cutler R, Graiziger C, Holtan SG, Rehman TU, et al. Dysbiosis patterns during re-induction/salvage versus induction chemotherapy for acute leukemia. Sci Rep. 2019;9: 6083. doi: 10.1038/s41598-019-42652-6 30988420

13. Staley C, Kaiser T, Vaugh BP, Graiziger CT, Hamilton MJ, Khoruts A, et al. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation. Microbiome. 2018;6: 166. doi: 10.1186/s40168-018-0549-6 30227892

14. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig WG, Peplies J, et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007;35: 7188–7196. doi: 10.1093/nar/gkm864 17947321

15. Huse SM, Welch DM, Morrison HG, Sogin ML. Ironing out the wrinkles in the rare biosphere through improved OTU clustering. Environ Microbiol. 2010;12: 1889–98. doi: 10.1111/j.1462-2920.2010.02193.x 20236171

16. Edgar RC, Haas BJ, Clemente JC, Quince C, Knight R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 2011;27: 2194–200. doi: 10.1093/bioinformatics/btr381 21700674

17. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, Farris RJ, et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009;37: D141–5. doi: 10.1093/nar/gkn879 19004872

18. Fang H, Ohlsson AK, Ullberg M, Özenci V. Evaluation of species-specific PCR, Bruker MS, VITEK MS and the VITEK 2 system for the identification of clinical Enterococcus isolates. Eur J Clin Microbiol Infect Dis. 2012;31: 3073–3077. doi: 10.1007/s10096-012-1667-x 22706514

19. Shannon CE, Weaver W. The Mathematical Theory of Communication. Urbana, IL: The University of Illinois Press; 1949.

20. Chalandon Y, Thomas X, Hayette S, Cayuela J-M, Abbal C, Huguet F, et al. Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia. Blood. 2015;125: 3711–3719. doi: 10.1182/blood-2015-02-627935 25878120

21. Ribera J-M, Oriol A, Morgades M, Montesinos P, Sarrà J, González-Campos J, et al. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial. J Clin Oncol. 2014;32: 1595–604. doi: 10.1200/JCO.2013.52.2425 24752047

22. Tedim AP, Ruiz-Garbajosa P, Corander J, Rodríguez CM, Cantón R, Willems RJ, et al. Population biology of intestinal enterococcus isolates from hospitalized and nonhospitalized individuals in different age groups. Macfarlane GT, editor. Appl Environ Microbiol. 2015;81: 1820–31. doi: 10.1128/AEM.03661-14 25548052

23. Toye B, Shymanski J, Bobrowska M, Woods W, Ramotar K. Clinical and epidemiological significance of enterococci intrinsically resistant to vancomycin (possessing the vanC genotype). J Clin Microbiol. 1997;35: 3166–70. Available: http://www.ncbi.nlm.nih.gov/pubmed/9399514 9399514

24. Moura TM de, Cassenego APV, Campos FS, Ribeiro AML, Franco AC, d’Azevedo PA, et al. Detection of vanC1 gene transcription in vancomycin-susceptible Enterococcus faecalis. Mem Inst Oswaldo Cruz. 2013;108: 453–6. doi: 10.1590/S0074-0276108042013009 23828012

25. Schwaiger K, Bauer J, Hörmansdorfer S, Mölle G, Preikschat P, Kämpf P, et al. Presence of the resistance genes vanC1 and pbp5 in phenotypically vancomycin and ampicillin susceptible Enterococcus faecalis. Microb Drug Resist. 2012;18: 434–9. doi: 10.1089/mdr.2011.0227 22524613

26. Tschudin Sutter S, Frei R, Dangel M, Gratwohl A, Bonten M, Widmer AF. Not All Patients with Vancomycin‐Resistant Enterococci Need To Be Isolated. Clin Infect Dis. 2010;51: 678–683. doi: 10.1086/655824 20687839

27. Andersson DI. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr Opin Microbiol. 2006;9: 461–5. doi: 10.1016/j.mib.2006.07.002 16890008

28. Andersson DI. Persistence of antibiotic resistant bacteria. Curr Opin Microbiol. 2003;6: 452–6. Available: http://www.ncbi.nlm.nih.gov/pubmed/14572536 14572536

29. MacPherson CW, Mathieu O, Tremblay J, Champagne J, Nantel A, Girard S-A, et al. Gut Bacterial Microbiota and its Resistome Rapidly Recover to Basal State Levels after Short-term Amoxicillin-Clavulanic Acid Treatment in Healthy Adults. Sci Rep. 2018;8: 11192. doi: 10.1038/s41598-018-29229-5 30046129


Článek vyšel v časopise

PLOS One


2019 Číslo 10

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Kurzy

Zvyšte si kvalifikaci online z pohodlí domova

Léčba bolesti v ordinaci praktického lékaře
nový kurz
Autoři: MUDr. PhDr. Zdeňka Nováková, Ph.D.

Revmatoidní artritida: včas a k cíli
Autoři: MUDr. Heřman Mann

Jistoty a nástrahy antikoagulační léčby aneb kardiolog - neurolog - farmakolog - nefrolog - právník diskutují
Autoři: doc. MUDr. Štěpán Havránek, Ph.D., prof. MUDr. Roman Herzig, Ph.D., doc. MUDr. Karel Urbánek, Ph.D., prim. MUDr. Jan Vachek, MUDr. et Mgr. Jolana Těšínová, Ph.D.

Léčba akutní pooperační bolesti
Autoři: doc. MUDr. Jiří Málek, CSc.

Nové antipsychotikum kariprazin v léčbě schizofrenie
Autoři: prof. MUDr. Cyril Höschl, DrSc., FRCPsych.

Všechny kurzy
Kurzy Doporučená témata Časopisy
Přihlášení
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.

Přihlášení

Nemáte účet?  Registrujte se